HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ralph A Schmid Selected Research
Ralph A Schmid Research Topics
Disease
35
Neoplasms (Cancer)
02/2023 - 01/2002
23
Lung Neoplasms (Lung Cancer)
11/2022 - 01/2002
15
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 01/2002
12
Malignant Mesothelioma
02/2023 - 08/2008
5
Neoplasm Metastasis (Metastasis)
01/2022 - 11/2010
5
Adenocarcinoma of Lung
04/2021 - 12/2013
4
Carcinogenesis
02/2023 - 03/2017
4
Proteinuria
10/2016 - 01/2002
3
Brain Neoplasms (Brain Tumor)
11/2022 - 11/2020
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2022 - 08/2018
3
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2021 - 11/2020
3
Lung Diseases (Lung Disease)
11/2020 - 02/2008
3
Wounds and Injuries (Trauma)
09/2017 - 02/2007
3
Lupus Nephritis
10/2016 - 08/2014
3
Lung Injury
01/2013 - 02/2007
2
Mesothelioma
01/2022 - 09/2008
2
Pneumonia (Pneumonitis)
10/2019 - 12/2015
2
Pain (Aches)
11/2018 - 04/2017
2
Infections
11/2017 - 02/2008
2
Respiratory Paralysis
04/2017 - 02/2008
2
Mediastinitis
01/2017 - 10/2012
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2016 - 07/2015
2
Paralysis (Palsy)
04/2016 - 12/2013
2
Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2013 - 02/2007
2
Fibrosis (Cirrhosis)
01/2013 - 02/2007
2
Febrile Neutropenia
08/2009 - 04/2005
2
Emphysema
05/2009 - 07/2008
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
12/2021
1
Anthracosis
12/2021
1
Microsatellite Instability
09/2021
1
Glioma (Gliomas)
07/2021
1
Respiratory Syncytial Virus Infections
01/2021
Drug/Important Bio-Agent (IBA)
9
Cisplatin (Platino)
FDA Link
Generic
01/2020 - 01/2002
5
Biomarkers (Surrogate Marker)
IBA
12/2022 - 01/2020
5
Pemetrexed (MTA)
FDA Link
01/2020 - 08/2010
4
B7-H1 Antigen
IBA
11/2022 - 11/2020
4
Ligands
IBA
01/2018 - 01/2002
3
Drug Combinations
IBA
01/2021 - 01/2019
3
DNA (Deoxyribonucleic Acid)
IBA
11/2020 - 08/2014
3
Enzymes
IBA
03/2017 - 08/2014
3
Irinotecan (Camptosar)
FDA Link
Generic
10/2016 - 08/2014
3
Topoisomerase I Inhibitors
IBA
10/2016 - 08/2009
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
07/2010 - 01/2002
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
02/2023 - 03/2010
2
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
07/2021 - 11/2020
2
erastin
IBA
04/2021 - 11/2020
2
Histone Deacetylases (Histone Deacetylase)
IBA
04/2021 - 11/2020
2
Epithelial Cell Adhesion Molecule
IBA
11/2020 - 01/2017
2
Eosine Yellowish-(YS) (Eosin)
IBA
11/2020 - 01/2020
2
Proteins (Proteins, Gene)
FDA Link
08/2019 - 01/2002
2
trioctyl phosphine oxide (TOPO)
IBA
10/2016 - 07/2015
2
Type I DNA Topoisomerases (Topoisomerase I)
IBA
10/2016 - 07/2015
2
Lidocaine (Xylocaine)
FDA Link
Generic
12/2013 - 02/2008
2
Hydroxyproline (4 Hydroxyproline)
IBA
01/2013 - 02/2007
2
Bleomycin (Blenoxane)
FDA Link
Generic
01/2013 - 02/2007
2
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
01/2013 - 02/2007
2
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
07/2010 - 08/2009
2
Camptothecin
IBA
08/2009 - 01/2002
2
Cytokines
IBA
08/2009 - 06/2006
1
Asbestos
IBA
02/2023
1
Methyltransferases
IBA
10/2022
1
Histones (Histone)
IBA
10/2022
1
Lysine (L-Lysine)
FDA Link
10/2022
1
Nuclear Proteins (Protein, Nuclear)
IBA
01/2022
1
Small Nucleolar Ribonucleoproteins
IBA
01/2022
1
Sirolimus (Rapamycin)
FDA Link
01/2022
1
ibrutinib
IBA
01/2022
1
Recombinant Proteins
IBA
01/2022
1
Nitrosamines
IBA
12/2021
1
Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)
IBA
12/2021
1
Amines
IBA
12/2021
1
Carbon
IBA
12/2021
1
Soot
IBA
12/2021
1
Dasatinib (BMS 354825)
FDA Link
07/2021
1
Histone Deacetylase Inhibitors
IBA
07/2021
1
Vorinostat
FDA Link
04/2021
1
Therapeutic Uses
IBA
04/2021
1
osimertinib
IBA
04/2021
1
Immune Checkpoint Inhibitors
IBA
03/2021
1
Chloroquine (Aralen)
FDA Link
Generic
01/2021
1
Polo-Like Kinase 1
IBA
01/2021
1
Antiviral Agents (Antivirals)
IBA
01/2021
1
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
01/2021
1
Oncogene Proteins (Oncogene Protein)
IBA
01/2021
Therapy/Procedure
29
Therapeutics
12/2022 - 04/2005
11
Drug Therapy (Chemotherapy)
01/2020 - 01/2002
6
Neoadjuvant Therapy
12/2022 - 05/2003
6
Pneumonectomy (Lung Volume Reduction)
04/2016 - 08/2008
5
Immunotherapy
12/2022 - 01/2020
5
Length of Stay
10/2019 - 11/2015
3
Sternotomy
11/2018 - 01/2002
3
Chest Tubes (Chest Tube)
09/2017 - 11/2015
3
Radiotherapy
12/2015 - 09/2008
2
Lasers (Laser)
12/2021 - 01/2018
2
Mechanical Ventilators (Ventilator)
09/2017 - 01/2017
2
Catheters
12/2013 - 02/2008
1
Induction Chemotherapy
12/2022
1
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2022
1
Cyclotrons
12/2021
1
Cranial Irradiation
04/2021